Adrabetadex to Treat Niemann-Pick Type C1 (NPC1) Disease
- First Posted Date
- 2021-07-12
- Last Posted Date
- 2023-08-29
- Lead Sponsor
- Mandos LLC
- Target Recruit Count
- 66
- Registration Number
- NCT04958642
- Locations
- 🇹🇷
Gazi University Medical Faculty, Ankara, Turkey
🇩🇪Universitaetsklinikum Mainz, Mainz, Germany
🇦🇺Monash Medical Centre, Clayton, Victoria, Australia
Open-label Study of VTS-270 in Participants With Neurologic Manifestations of Niemann-Pick Type C1
- First Posted Date
- 2019-03-19
- Last Posted Date
- 2023-12-26
- Lead Sponsor
- Mandos LLC
- Target Recruit Count
- 2
- Registration Number
- NCT03879655
- Locations
- 🇨🇷
Hospital Clinica Biblica, San José, Costa Rica
Niemann-Pick Type C Treatment With Adrabetadex for Symptoms of Brain and Nervous System
- First Posted Date
- 2018-08-23
- Last Posted Date
- 2024-01-17
- Lead Sponsor
- Mandos LLC
- Target Recruit Count
- 27
- Registration Number
- NCT03643562
- Locations
- 🇺🇸
Rare Disease Research, LLC, Atlanta, Georgia, United States
🇺🇸Rush University Medical Center, Chicago, Illinois, United States
🇺🇸Gillette Children's Specialty Healthcare, Saint Paul, Minnesota, United States
VTS-270 to Treat Niemann-Pick Type C1 (NPC1) Disease
Phase 2
Completed
- Conditions
- Niemann-Pick Disease, Type C
- First Posted Date
- 2015-08-28
- Last Posted Date
- 2023-02-22
- Lead Sponsor
- Mandos LLC
- Target Recruit Count
- 56
- Registration Number
- NCT02534844
- Locations
- 🇪🇸
Hospital Universitario del Valle Hebron, Barcelona, Spain
🇺🇸The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
🇸🇬National University Hospital (Singapore) Pte, Ltd, Singapore, Singapore
© Copyright 2025. All Rights Reserved by MedPath